Sanofi India Limited (SANOFI) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.585x

Based on the latest financial reports, Sanofi India Limited (SANOFI) has a cash flow conversion efficiency ratio of 0.585x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.38 Billion ≈ $47.40 Million USD) by net assets (Rs7.49 Billion ≈ $81.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sanofi India Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Sanofi India Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Sanofi India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sanofi India Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sanofi India Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
-0.073x
Standard Lithium Ltd
V:SLI
-0.016x
Daheng New Epoch Technology Inc
SHG:600288
0.025x
Beijing Asiacom Information Technology Co.Ltd
SHE:301085
N/A
Intelbras S.A. - Indústria de Telecomunicação Eletrônica Brasileira
SA:INTB3
0.150x
Veken Elite
SHG:600152
0.045x
Shanghai Haohai Biological Tech Co
SHG:688366
0.019x
YCC CORP
KQ:232140
0.072x

Annual Cash Flow Conversion Efficiency for Sanofi India Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Sanofi India Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see SANOFI company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rs7.49 Billion
≈ $81.02 Million
Rs4.51 Billion
≈ $48.76 Million
0.602x +12.23%
2024-12-31 Rs8.61 Billion
≈ $93.07 Million
Rs4.62 Billion
≈ $49.91 Million
0.536x +136.29%
2023-12-31 Rs10.15 Billion
≈ $109.79 Million
Rs2.30 Billion
≈ $24.92 Million
0.227x -27.38%
2022-12-31 Rs12.76 Billion
≈ $137.97 Million
Rs3.99 Billion
≈ $43.12 Million
0.313x +24.47%
2021-12-31 Rs22.26 Billion
≈ $240.69 Million
Rs5.59 Billion
≈ $60.43 Million
0.251x -12.94%
2020-12-31 Rs21.19 Billion
≈ $229.16 Million
Rs6.11 Billion
≈ $66.09 Million
0.288x +70.83%
2019-12-31 Rs24.42 Billion
≈ $264.13 Million
Rs4.12 Billion
≈ $44.59 Million
0.169x +0.20%
2018-12-31 Rs22.19 Billion
≈ $240.00 Million
Rs3.74 Billion
≈ $40.44 Million
0.168x -21.53%
2017-12-31 Rs20.26 Billion
≈ $219.15 Million
Rs4.35 Billion
≈ $47.05 Million
0.215x +15.52%
2016-12-31 Rs17.36 Billion
≈ $187.70 Million
Rs3.23 Billion
≈ $34.89 Million
0.186x +41.87%
2015-12-31 Rs16.27 Billion
≈ $175.97 Million
Rs2.13 Billion
≈ $23.05 Million
0.131x -26.53%
2014-12-31 Rs14.86 Billion
≈ $160.69 Million
Rs2.65 Billion
≈ $28.65 Million
0.178x -11.89%
2013-12-31 Rs13.47 Billion
≈ $145.64 Million
Rs2.73 Billion
≈ $29.48 Million
0.202x -14.90%
2012-12-31 Rs12.04 Billion
≈ $130.22 Million
Rs2.86 Billion
≈ $30.97 Million
0.238x +29.53%
2011-12-31 Rs11.17 Billion
≈ $120.76 Million
Rs2.05 Billion
≈ $22.17 Million
0.184x +42.45%
2010-12-31 Rs10.14 Billion
≈ $109.68 Million
Rs1.31 Billion
≈ $14.14 Million
0.129x -12.71%
2009-12-31 Rs9.32 Billion
≈ $100.77 Million
Rs1.38 Billion
≈ $14.88 Million
0.148x +2.28%
2008-12-31 Rs8.29 Billion
≈ $89.66 Million
Rs1.20 Billion
≈ $12.95 Million
0.144x -1.97%
2007-12-31 Rs7.07 Billion
≈ $76.44 Million
Rs1.04 Billion
≈ $11.26 Million
0.147x -27.73%
2006-12-31 Rs6.08 Billion
≈ $65.78 Million
Rs1.24 Billion
≈ $13.40 Million
0.204x -32.31%
2005-12-31 Rs5.24 Billion
≈ $56.65 Million
Rs1.58 Billion
≈ $17.05 Million
0.301x +77.53%
2004-12-31 Rs4.22 Billion
≈ $45.62 Million
Rs715.33 Million
≈ $7.74 Million
0.170x --

About Sanofi India Limited

NSE:SANOFI India Drug Manufacturers - General
Market Cap
$839.48 Million
Rs77.62 Billion INR
Market Cap Rank
#9848 Global
#488 in India
Share Price
Rs3370.50
Change (1 day)
+2.01%
52-Week Range
Rs3097.10 - Rs6371.50
All Time High
Rs10072.65
About

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targoci… Read more